Upgrading Hanger Ortho to Buy

Tags: hgr
2 May 3:19am
Read original blog entry

First quarter EPS doubled on lower variable interest rate expense. Sales grew 9.6%, driven by strong patient care center growth. Operating margin gained 40 basis points due to higher gross margins and lower sales, general and administrative (SG&A) expenses. Effective tax rate declined 160 basis points to 40%. Hanger Orthopedic Group, Inc. (HGR) guided 2008 EPS higher by five cents to $0.75-$0.77.


The company produced better-than-expected first quarter results, helped by strong 26% growth in distribution and a lower variable interest rate on debt. The sales growth was due to a $5.5 million or 4.2% increase in same-center sales in patient care business, a $3.4 million or 25.7% increase in outside sales of the distribution segment, and a $4.9 million increase from acquired entities.


The increase in SG&A was due to acquisition-related expenses, investment in growth strategies, and higher merit salaries and fixed overhead expenses. Importantly, another Medicare fee increase of will help 2008 results.


We are raising our estimates on the out-performance, and our 2008 EPS estimate is in-line with the company's range, two cents above our prior estimate. We believe the company should trade in-line with comparables.


Our target moves to $16, or roughly 21x our expected 2008 EPS of $0.76, in-line with the industry 1.3x median P/E/G and comparables 1.5x 2008 P/E/G average. We are changing our rating to a Buy based upon valuation, strong fundamentals, and the company s industry leadership position.


Read the full analyst report on HGR.



Get real-time market insights and profitable stock recommendations from the team of analysts at Zacks Equity Research. See all today’s Analyst Blog entries on Zacks.com.

Comments

Back to top

Post comment

Back to top

Post a comment

Please login to post a comment

About

ZacksResearch

Zacks Investment Research is one of the most highly regarded firms in the investment industry. Our firm has long believed that that quantitative models (like the Zacks Rank) can predict stock prices more accurately than individual analysts. However we also recognize that models are most effective when they are employed by analysts who have deep fundamental knowledge of the company and its industry. Consequently Zacks Equity Research combines Zacks quantitative models with the insight provided by an experienced team of 50 analysts to create superior long term stock recommendations. Discover all their timely insight and recommendations daily on Zacks.com.